Literature DB >> 19152185

Pathogenic mechanisms in the initiation and progression of mammary phyllodes tumours.

Rooshdiya Z Karim1, Richard A Scolyer, Gary M Tse, Puay-Hoon Tan, Thomas C Putti, C Soon Lee.   

Abstract

Mammary phyllodes tumours (PTs) are rare fibroepithelial neoplasms of the breast. They have a propensity to recur locally and the ability to metastasise. There is some correlation between the histological parameters of PTs and their biological behaviour; however, no single feature or grading scheme can accurately predict the behaviour of a PT. The PTs that will recur and/or metastasise are not being precisely delineated with the currently available diagnostic tools. A number of pathways/markers have been implicated in the pathogenesis of PTs including hormone receptors, members of the Wnt pathway, cell cycle proteins, factors involved in angiogenesis, tyrosine kinase receptors and matrix metalloproteases. The currently available evidence supports a model where initiation of PTs involves interactions between the epithelium and stroma and these interactions are lost with the progression to malignancy such that growth of the stroma becomes autonomous of the epithelium. Loss of the stromal-epithelial interdependancy, increased stromal proliferation, angiogenesis and matrix alterations appear to be involved in the progression to malignancy.

Entities:  

Mesh:

Year:  2009        PMID: 19152185     DOI: 10.1080/00313020802579342

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  6 in total

1.  The clinical features and prognosis of phyllodes tumors: a single institution experience in Taiwan.

Authors:  Chin-Chan Lin; Hui-Wen Chang; Chen-Yuan Lin; Chang-Fang Chiu; Shin-Pen Yeh
Journal:  Int J Clin Oncol       Date:  2012-07-07       Impact factor: 3.402

2.  A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway.

Authors:  Ashley Cimino-Mathews; Jessica L Hicks; Rajni Sharma; Russell Vang; Peter B Illei; Angelo De Marzo; Leisha A Emens; Pedram Argani
Journal:  Hum Pathol       Date:  2013-07-31       Impact factor: 3.466

Review 3.  Phyllodes tumours of the breast: a consensus review.

Authors:  Benjamin Y Tan; Geza Acs; Sophia K Apple; Sunil Badve; Ira J Bleiweiss; Edi Brogi; José P Calvo; David J Dabbs; Ian O Ellis; Vincenzo Eusebi; Gelareh Farshid; Stephen B Fox; Shu Ichihara; Sunil R Lakhani; Emad A Rakha; Jorge S Reis-Filho; Andrea L Richardson; Aysegul Sahin; Fernando C Schmitt; Stuart J Schnitt; Kalliopi P Siziopikou; Fernando A Soares; Gary M Tse; Anne Vincent-Salomon; Puay Hoon Tan
Journal:  Histopathology       Date:  2016-01       Impact factor: 5.087

4.  SETD2 alterations and histone H3K36 trimethylation in phyllodes tumor of breast.

Authors:  Julia Y Tsang; Sui-Ting Lai; Yun-Bi Ni; Yan Shao; Ivan K Poon; Johnny S Kwan; Chit Chow; Ka-Ho Shea; Gary M Tse
Journal:  Breast Cancer Res Treat       Date:  2021-04-12       Impact factor: 4.872

5.  Lactation defect with impaired secretory activation in AEBP1-null mice.

Authors:  Lei Zhang; Shannon P Reidy; Oleg Bogachev; Brian K Hall; Amin Majdalawieh; Hyo-Sung Ro
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

6.  Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells.

Authors:  Jin-Jin Lin; Chiun-Sheng Huang; John Yu; Guo-Shiou Liao; Huang-Chun Lien; Jung-Tung Hung; Ruey-Jen Lin; Fen-Pi Chou; Kun-Tu Yeh; Alice L Yu
Journal:  Breast Cancer Res       Date:  2014-03-26       Impact factor: 6.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.